Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jean-Baptiste Briere"'
Publikováno v:
Journal of Medical Economics
Journal of Medical Economics, 2020, 23 (10), ⟨10.1080/13696998.2020.1792917⟩
Journal of Medical Economics, 2020, 23 (10), ⟨10.1080/13696998.2020.1792917⟩
Real-world evidence (RWE) provides external validity, supplementing and enhancing the randomized controlled trial data with valuable information on patient behaviors and outcomes, turning efficacy and safety results into real-world effectiveness and
Autor:
Stefan J. Cano, Takeshi Yamashita, Jean-Baptiste Briere, Koichiro Kumagai, Yukihiro Koretsune, Gavin Dickie, Sayako Akiyama, Masahiro Yasaka, Benjamin Banderas, Emi Watanabe-Fujinuma, Shinichiro Uchiyama
Publikováno v:
Journal of Medical Economics. 22:798-805
Aims: The Anti-Clot Treatment Scale (ACTS) and Treatment Satisfaction Questionnaire for Medication version II (TSQM-II) are validated treatment satisfaction patient-reported outcome (PRO) i...
Autor:
Sayako Akiyama, Masahiro Yasaka, Emi Watanabe-Fujinuma, Yutaka Okayama, Yukihiro Koretsune, Shinichiro Uchiyama, Benjamin Banderas, Takeshi Yamashita, Stefan J. Cano, Koichiro Kumagai, Gavin Dickie, Jean-Baptiste Briere
Publikováno v:
Current Medical Research and Opinion. 34:2157-2164
Rivaroxaban has previously been shown to be as efficacious and safe as warfarin for the prevention of stroke in non-valvular atrial fibrillation (NVAF). Therefore, treatment satisfaction becomes an important consideration. Here we examine treatment s
Publikováno v:
Journal of Medical Economics. 20:599-605
Vitamin K antagonists (VKAs) are used for stroke prevention in patients with non-valvular atrial fibrillation (NVAF), but necessitate regular monitoring of prothrombin time via international normalized ratio (INR) testing. This study explores the eco
Autor:
Yukihiro Koretsune, Calypso Montouchet, Emi Watanabe-Fujinuma, Masatsugu Hori, Lewis Ruff, Shunya Ikeda, Thomas Evers, B. Rossi, Jean-Baptiste Briere, Shinya Matsuda, Ken Okumura
Publikováno v:
Journal of Medical Economics. 19:889-899
Atrial fibrillation (AF) affects an estimated 1.5 million individuals in Japan, increasing their stroke risk and imposing considerable costs on the Japanese healthcare system. To reduce stroke incidence, guidelines recommend using anticoagulants in m
Autor:
B. Rossi, E.C.Y. Wang, Yukihiro Koretsune, Marco DiBonaventura, Jean-Baptiste Briere, Kazuya Iwamoto
Publikováno v:
Research Reports in Clinical Cardiology. :97
Yukihiro Koretsune,1 Bruno Rossi,2 Kazuya Iwamoto,3 Edward CY Wang,4 Marco DiBonaventura,5 Jean-Baptiste Briere41Institute for Clinical Research, Osaka National Hospital, Osaka, Japan; 2Market Access, Bayer Yakuhin Ltd., Osaka, Japan; 3Medical Affair